QRVO
1
-12
CHD
32
-8
AA
22
-2
DUK
47
-3
ALLE
10
-20
AMZN
37
-3
OI
17
-7
EXPE
48
-2
AVY
37
-4
T
50
-3
SRE
26
-2
L
45
6
DVN
11
-5
LYB
2
-6
INTC
14
-6
SHW
33
-4
KSS
12
-3
SLG
31
-4
AVGO
3
2
MDLZ
40
-4
QRVO
1
-12
CHD
32
-8
AA
22
-2
DUK
47
-3
ALLE
10
-20
AMZN
37
-3
OI
17
-7
EXPE
48
-2
AVY
37
-4
T
50
-3
SRE
26
-2
L
45
6
DVN
11
-5
LYB
2
-6
INTC
14
-6
SHW
33
-4
KSS
12
-3
SLG
31
-4
AVGO
3
2
MDLZ
40
-4
Financhill
Back

Integra Lifesciences Holdings Stock Predictions

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
4

IART
Integra Lifesciences Holdings

Last Price:
$19.22
Seasonality Move:
3.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Integra Lifesciences Holdings Stock Forecast

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 10.7% based on the past 29 years of stock performance.
  • Integra Lifesciences Holdings has risen higher in 18 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.07%
  • Is Integra Lifesciences Holdings Stock Undervalued?
    The current Integra Lifesciences Holdings [IART] share price is $18.07. The Score for IART is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • IART is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Integra Lifesciences Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 10.7% based on the past 29 years of stock performance.

Integra Lifesciences Holdings Stock Rating

Sell
4
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings overpriced?

  • Integra Lifesciences Holdings has risen higher in 18 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.07%

Integra Lifesciences Holdings Stock Price History

Is IART stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IART is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
integralife.com

52-Week Data

52-Week High:
34.79
52-Week Low:
16.81

Prediction Charts

Market Cap:
1.8B
Price in USD:
18.07
Volume:
830.8K
Beta:
0.94

Technical Analysis

SMA50:
23.27
SMA100:
23.32
SMA200:
23.04
52-Wk Change:
-38.44%

Stock Predictions

  • Is Integra Lifesciences Holdings stock public?
    Yes, Integra Lifesciences Holdings is a publicly traded company.
  • What is the Integra Lifesciences Holdings stock quote today?
    The Integra Lifesciences Holdings stock price is 18.07 USD today.
  • How to buy Integra Lifesciences Holdings stock online?
    You can buy Integra Lifesciences Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-20 22.59 22.71 23.16 22.30
Mar-21 22.40 22.49 22.75 22.21
Mar-24 22.88 22.64 22.96 22.36
Mar-25 22.54 22.18 22.83 21.89
Mar-26 22.09 21.82 22.35 21.49
Mar-27 21.80 22.01 22.20 21.55
Mar-28 21.92 21.69 22.08 21.45
Mar-31 21.98 21.99 22.27 21.74
Apr-1 21.93 21.61 21.95 21.35
Apr-2 21.19 21.78 21.88 21.19
Apr-3 21.23 20.06 21.34 20.04
Apr-4 19.38 19.57 19.86 18.90
Apr-7 18.77 19.58 20.41 18.53
Apr-8 20.15 18.07 20.55 17.86

Integra Lifesciences Holdings Earnings

Integra Lifesciences Holdings Earnings Report: Per Share Integra Lifesciences Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Integra Lifesciences Holdings Forecast Revenue Growth

Integra Lifesciences Holdings Stock Analysis: Historical quarterly revenues per share for Integra Lifesciences Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.26 per share.

* Integra Lifesciences Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.